(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...

Metro Loft and David Werner’s secured $720 million of construction financing to execute New York City’s largest office-resi ...

ACME Solar Holdings, DLF, Eris Lifesciences, Gujarat Gas, HEG, Hindustan Foods, Petronet LNG, Pfizer, Restaurant Brands Asia ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...

The Novavax Covid-19 vaccine, which uses more traditional protein-based technology than the mRNA vaccines from ...

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.

One possible explanation for the gap is the availability of highly efficacious CAR-T therapies in the U.S. and Europe serving ...

The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...